You are here : Home » Get Involved » MSRC Interactive » Gilenya® User Diaries

Gilenya® User Diaries

Share |

Gilenya To aid those who may have been prescribed Gilenya^® or those thinking of asking their Neurologist to prescribe Gilenya^® we at the MSRC have enlisted the help of people with MS who are now currently taking Gilenya^® to provide some insight into how they went about getting the drug and how the drug has changed, or not, their condition.

If you are currently taking Gilenya^®, and would like to join our panel of "Diarists" please contact the MSRC Webmaster at [email protected]

Gilenya® (fingolimod) is the first in a new class of disease-modifying treatments called sphingosine 1-phosphate receptor (S1P-R) modulators and has a novel mode of action different from all currently marketed MS therapies.

Gilenya^®Diarists

Kim (updated 09/07/12)
Liz (Updated 02/04/12)
Mike (Updated 23/04/12)
Toots Mstruth (Updated 30/11/12)
Debbie (Updated 29/06/12)

© Multiple Sclerosis Resource Centre

Related Items

Debbie's Gilenya Diary

Kim's Gilenya Diary

Liz's Gilenya Diary

Mike's Gilenya Diary

Toots Mstruth

Have Your Say

Help, Advice and Inspiration from people with MS

Stella's Haematopoietic Stem Cell Transplantation (HSCT) Blog

Tysabri® User Diaries

Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.